Cargando…
Pocket guide to gastrointestinal drugs /
"Learn all you need to know about gastrointestinal drugs and their clinical use with this one-stop, rapid reference pocket guide. Brought to you by many of the world's leading GI drug experts, Pocket Guide to Gastrointestinal Drugs provides comprehensive guidance to the pharmacological pro...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Chichester, West Sussex :
John Wiley & Sons,
2014.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Cover; Title Page; Copyright; List of contributors; Preface; PART I: UPPER GI TRACT; Chapter 1: Prokinetic agents and antiemetics; Prokinetics; Antiemetic agents; Recommended reading; Chapter 2: Proton pump inhibitors; Introduction; Mechanism of action, pharmacodynamics, kinetics; Clinical use and dosing; Adverse effects/safety; Recommended reading; Chapter 3: Histamine H2-receptor antagonists; Introduction; Mechanism of action; Pharmacology; Clinical effectiveness; Adverse events; Recommended reading; Chapter 4: Prostaglandins and other mucosal protecting agents; Introduction of drug class.
- Physicochemical propertiesFormulations and recommended dosages; Mechanism of action; Drug interactions; Pharmacokinetics; Clinical effectiveness; Toxicity; Pregnancy classes; Other mucosal protecting agents; Recommended reading; PART II: SMALL AND LARGE INTESTINE; Chapter 5: 5-HT modulators and other antidiarrheal agents and cathartics; Introduction; 5-HT modulators used in the management of GI disorders; 5-HT agents approved in the US for specific GI indications; Medications used for the treatment of chronic constipation; Medications used for the treatment of narcotic-induced constipation.
- Antidiarrheal agentsConclusion; Recommended reading; Chapter 6: 5-aminosalicylates; Introduction; Preparations; Clinical use and efficacy; Pharmacology: preparations and dosing; Mechanism of action; Bioavailability and metabolism; Adverse effects and toxicity; Pregnancy (Table 6.7); Drug interactions (package inserts); Precautions and contraindications (Table 6.8); Special considerations: effectiveness in colorectal cancer prevention; Conclusion (Table 6.9); Recommended reading; Chapter 7: Immunosuppressive agents; Introduction; Thiopurines; Low-dose methotrexate (MTX); Calcineurin inhibitors.
- Recommended readingChapter 8: Biological agents; Biological agents approved to treat IBD; Optimal treatment strategies with anti TNF therapies in IBD; Safety of biological agents in IBD; Emerging biologicals; Recommended reading; PART III: LIVER AND PANCREAS; Chapter 9: Interferons; Introduction; Mechanism of action; Pharmacology; Clinical effectiveness; Toxicity; Interferon types with generic and brand names; Pregnancy classes; Initial interferon dosing regimens for chronic hepatitis C; Recommended reading; Chapter 10: Nucleoside analogs; Introduction; Mechanism of action; Pharmacology.
- Clinical effectivenessNucleoside analogs; Nucleotide analogs; Summary; Recommended reading; Chapter 11: Ursodeoxycholic acid, chelating agents, and zinc in the treatment of metabolic liver diseases; Ursodeoxycholic acid; Treatment of copper overload; Recommended reading; Chapter 12: Agents for the treatment of portal hypertension; Introduction; Nonselective beta-blockers (NSBB); Nitrates; Vasopressin analogs; Somatostatin analog; Midodrine; Albumin; Loop diuretics; Aldosterone antagonist; Aquaretics; Disaccharides; Antibiotics; Recommended reading; Chapter 13: Pancreatic enzymes; Introduction.